Human Longevity Expands AI-Driven Lung Cancer Detection Initiative
Human Longevity, Inc. has expanded its $1 million cancer pledge to include lung cancer, the world's deadliest cancer, announced in a press release. This initiative is part of the company's commitment to precision prevention and early detection through its Executive Health Program and 100+ Longevity Programs.
The program integrates advanced AI-driven diagnostics, including whole genome sequencing, volumetric MRI, and multi-cancer early detection blood tests. Participants in these programs undergo continuous monitoring for respiratory symptoms and biomarkers, aiming to detect lung cancer at earlier, more treatable stages.
Eligible members diagnosed with late-stage lung cancer while enrolled in the program can receive up to $1 million in clinical support, including treatment coordination and consultations with top thoracic oncology experts. This initiative underscores Human Longevity's focus on proactive healthcare, leveraging AI and genomics to enhance early cancer detection and personalized care.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Sep 15 LexisNexis Adds MyChart Identity Proofing to Epic Toolbox Sep 15 Sensei Partners With Zentist for Dental EOB Automation Sep 15 MGI Tech Launches VisiOmics in Europe Sep 15 Deloitte Launches Agentforce CRM Accelerator for Life Sciences Sep 14 Inductive Bio Launches Indy Chemistry AssistantLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Whitepaper
Tensordyne Napier: What If One Rack Could Do the Work of Nine?
Tensordyne
This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.
Read moreYou may also like
Atman Health Wins ARPA-H Award to Build Heart Failure AI
Probably Genetic Gets Up to $10M ARPA-H Contract for Rare Disease AI
PrecisionLife Selects Gencove for US DNA Wellness Reports
ARPA-H Awards UpDoc Up to $9.2 Million for Clinical AI
NYU Langone AI Uses Multiple 3D Mammograms to Predict Breast Cancer Risk
Daily AI Brief: the AI news that matters, in your inbox.